Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2009
10/14/2009CN101557823A Human endogenous retrovirus polypeptide compositions and methods of use thereof
10/14/2009CN101557822A Vaccin against group a beta hemolytic streptococcus and respective process for obtaining thereof
10/14/2009CN101557820A Omega conotoxins
10/14/2009CN101557819A Use of modified cyclosporins
10/14/2009CN101557818A ATAP peptides, nucleic acids encoding the same and associated methods of use
10/14/2009CN101557817A Albumin fusion proteins
10/14/2009CN101557813A Liposome treatment of viral infections
10/14/2009CN101557803A Liposome containing cardiolipin for improvement of mitochondrial function
10/14/2009CN101555482A Fusion protein of human parathyrine (1-34) diad and human seralbumin and preparation thereof
10/14/2009CN101555468A Viral variants with altered susceptibility to nucleoside analogs and uses thereof
10/14/2009CN101555283A Antibodies to non-functional p2x7 receptor, diagnosis and treatment of cancers and other conditions
10/14/2009CN101555279A Urinary follicle stimulating hormone with high purity and preparation method thereof
10/14/2009CN101554479A Pharmaceutical composition containing an iron-binding agent
10/14/2009CN101554475A Use of secondary heme short peptide compound in preparation of anti-cerebral ischemia drugs
10/14/2009CN101554474A Application of PTD-SOD fusion protein to anti-fatigue product
10/14/2009CN101554473A Method for preparing compound with hypoglycemic function containing cornu cervi pantotrichum insulin-like active factors
10/14/2009CN101554472A Novel medical compound being capable of synergetically suppressing growth of tumors
10/14/2009CN101554389A Botulinus toxin composition and preparation method thereof
10/14/2009CN101554386A Medicine composition for curing hepatic disease and preparation method thereof
10/14/2009CN101554237A Preparation method of oxalate-degrading enzyme contained in plant fiber or microorganism indissolvable component and applications
10/14/2009CN100549175C Recombinant protein with cancer suppression action and its encoding gene and use
10/14/2009CN100549171C Polynucleotide for target gene
10/14/2009CN100549165C Calcineurin of clonorchis sinensis, its coding nucleic acid and application
10/14/2009CN100549031C Mutated nonactivating IgG2 domains and anti-cd3 antibodies incorporating same
10/14/2009CN100549030C Modified IL-4 mutein receptor antagonists
10/14/2009CN100548386C Releasable polymeric conjugates based on biodegradable linkers
10/14/2009CN100548372C Preparation of alpha-1 protein inhibitor
10/14/2009CN100548371C Composition containing lactobacillus acidophilus and application thereof
10/14/2009CN100548370C Spray for treating burns, scalds and chronic ulcer and its preparation
10/14/2009CN100548369C Body fat percentage-lowering agent or body fat percentage increasing inhibitor
10/14/2009CN100548303C Combination product comprising melagatran and dexamethasone
10/14/2009CN100548291C MCH antagonists for the treatment of obesity
10/14/2009CN100548277C Preparing method of powder agglomerates
10/14/2009CN100548272C Composition comprising colony stimulating factor for treatment of a localized bacterial infection and bacterial related disease
10/14/2009CN100548157C Compositions comprising milk protein concentrate and fatty acid and processes of their preparation
10/13/2009US7601827 Polynucleotides encoding polypeptides that bind to the P185HER2 receptor
10/13/2009US7601826 Genes and polypeptides relating to human pancreatic cancers
10/13/2009US7601816 Transcripts harboring inton 1, or fragment thereof; preventing or treating Alzheimer's Disease; ameliorating a neurodegenerative condition; modulating amyloid precursor protein; selectively inhibiting COX-3 or PCOX-1a activity
10/13/2009US7601815 For controlling development, differentiation, trafficking, and physiology of mammalian cells; diagnosis
10/13/2009US7601814 Reduce binding to epitope to fusion protein; reduce its ability to interact with a T cell receptor; use in immunotherapy
10/13/2009US7601813 Anti-GL50 antibodies
10/13/2009US7601812 Schistosoma protein for use in treatment of organ-specific autoimmune diseases
10/13/2009US7601810 insecticidal proteins encoded by naturally-occurring and recombinant nucleic acids, has the activity against plant pathogens
10/13/2009US7601803 mutagenized bovine gamma-II-crystallin polypeptide with binding to the Hormone Estradiol; antibodies, enzymes
10/13/2009US7601802 Cysteine-containing peptides having antioxidant properties
10/13/2009US7601801 polypeptide with binding to antigen and is recognized by cytotoxic T lymphocytes; use as cancer vaccine
10/13/2009US7601800 monitor a patient's response to glutamine supplementation undergoing radiation therapy; correlating the increase in the amount of serum proteins to the extent of protection of breast tissue against radiation injury
10/13/2009US7601799 Methods and means to promote gut absorption
10/13/2009US7601753 Pyrrolidine melanocortin-specific compounds
10/13/2009US7601735 Antiviral compounds
10/13/2009US7601731 Antimicrobial flush solutions
10/13/2009US7601727 Such as 3-{4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile; janus kinase 3 inhibitors; immunosuppressive agents; asthma
10/13/2009US7601709 Macrocyclic hepatitis C serine protease inhibitors
10/13/2009US7601708 Providing sustained systemic concentrations of therapeutic or prophylactic agents such as gamma-aminobutyric acid derivatives following oral adiminstration to animals
10/13/2009US7601706 Bile-acid conjugates providing for sustained systemic concentration of drugs
10/13/2009US7601700 Modified antisense oligonucleotide; antitumor and anticancer agents
10/13/2009US7601697 Polypeptides; nucleic acid molecules and viral vectors which direct gene expression of such polypeptides; vaccines; genetic engineering; transfecting cells of animal ex vivo with nucleic acid molecule and delivering transfected cells animal
10/13/2009US7601694 Inhibiting angiogenesis, tumor growth and metastasis in the tissue of a mammal by administering to the mammal an active agent comprising an angiogenesis-inhibiting amount of a selective antagonist of denatured collagen type-IV
10/13/2009US7601692 Monocyte Chemoattractant Protein 1 (MCP-1); useful to treat various MCP-1 related disorders as well as for diagnosing, determining predisposition and/or prognosis of various disorders
10/13/2009US7601691 PYY peptide or a functional derivative, coupled to a reactive group( michael acceptor, maleimides or succnimides) capable of reacting on a blood component so as to form a stable covalent bond
10/13/2009US7601690 Cross-linked glycopeptide-cephalosporin antibiotics
10/13/2009US7601689 Mixture comprising stabilized neovascularization protein; for use in management of hypertension, hyperlipidemia, diabetes and chronic fatigue syndrome
10/13/2009US7601688 Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus
10/13/2009US7601687 Drug screening for non-insulin dependent diabetes mellitus, beta cell dysfunction and peripheral insulin resistance
10/13/2009US7601686 Serine protease inhibition via 1-{[1-(2-Methoxycarbonylamino-3,3-dimethyl-butyryl)-4-(7-methoxy-2-phenyl-quinolin-4-yloxy)-pyrrolidine-2-carbonyl]-amino}-2-vinyl-cyclopropanecarboxylic acid
10/13/2009US7601685 Comprises fusion proteins for use in microarray designed for tissue repair, regeneration and/or remodeling and/or drug delivery
10/13/2009US7601684 Test strips; medical diagnosis
10/13/2009US7601683 Protein conformational isomers, methods of making, methods for using, compositions comprising and products made therewith
10/13/2009US7601540 Gamma secretase notch biomarkers
10/13/2009US7601516 Follicle stimulating hormone-immunoglobulin fusion fo use in treatment of reproductive disorders
10/13/2009US7601508 Ecdysone receptor polypeptide from the homopteran whitefly (Bamecia argentifoli, BaEcR) use screening for monoclonal antibodies; biological insecticides
10/13/2009US7601496 Exonucleases; solid phase synthesis
10/13/2009US7601366 Promotion of peroxisomal catalase function in cells
10/13/2009US7601365 Synergetic effects of HGF and antibacterial treatment
10/13/2009US7601361 Treating with formaldehyde; durability; polyamides, polyurethanes and polyureas as substrates; hydroxymethylation catalysts
10/13/2009US7601359 Compositions and methods for the prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress proteins
10/13/2009US7601354 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
10/13/2009US7601352 Monoclonal antibodies and antigen binding fragments thereof capable of binding TrkA and inhibiting the functional activation of TrkA
10/13/2009US7601349 GIPs, a family of polypeptides with transcription factor activity that interact with Goodpasture antigen binding protein
10/13/2009US7601342 Producing a substantially pure cytotoxic population of educated, antigen-specific immune effector cells as adoptive immunostimulants;using hybrid cells generated by fusion of a dendritic cell and a tumor or cancer cell that expresses cell-surface antigens; antitumor agents; anticarcinogenic agents
10/13/2009US7601341 conjugate is cytotoxic to cells expressing more than 2000 type 2 VEGF receptors per celll fusion protein with cytotoxic molecule such as gelonin or granzyme B or Bax
10/13/2009US7601338 Dentifrice and mouthwash compositions comprising an enzyme having waterinsoluble impurities and a cyclodextrin which complexes with the impurity to form a waterform an insoluble complex; papain or other proteolytic enzymes; impurities including lipohilic and sulfur compounds;ketones; organoleptic
10/13/2009US7601157 Devices and methods for the restoration of a spinal disc
10/13/2009CA2590537C The use of the neurotoxin component of a botulinum toxin for the treatment of excessive lacrimation
10/13/2009CA2504747C Pharmaceutical antidiabetic composition
10/13/2009CA2473070C Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatites c virus infection
10/13/2009CA2472373C Combination of paclitaxel and a polymer
10/13/2009CA2455246C Drug preparation comprising .alpha.-lipoic acid, ambroxol and/or inhibitors of the angiotensin-converting enzyme (ace) and its use for the treatment of neurodegenerative diseases
10/13/2009CA2438910C Amphoteric sterols and the use thereof in the production of ph-sensitive liposomes
10/13/2009CA2395438C Dry compositions containing hydrophobic amino acid
10/13/2009CA2370830C Use of 2,4-diamino-3-hydroxycarboxylic acid derivatives as proteasome inhibitors
10/13/2009CA2356331C Methods for glucagon suppression
10/13/2009CA2334775C Benzo(b)thiepine-1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
10/13/2009CA2323925C Crosslinkable macromers bearing initiator groups
10/13/2009CA2309278C Biodegradable, anionic polymers derived from the amino acid l-tyrosine
10/13/2009CA2274967C Methods and compositions for treating pain
10/13/2009CA2236888C Medicament, in particular for modulation of the immune response in the control of viruses, tumors, bacteria and parasites
10/13/2009CA2234263C Pharmaceutical composition for treating papillomavirus tumours and infection
10/13/2009CA2224413C Immunovectors for the intracellular and intranuclear transport
10/13/2009CA2222650C Tnf-.alpha. converting enzyme
1 ... 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 ... 3163